Scott McTominay and the €30m transfer illusion: When Manchester United wants to buy back its former player

In August 2026, Scott McTominay left Manchester United after more than two decades with the academy and the first team. Napoli paid 30 million euros. There was no grand farewell ceremony, no collective tears at Old Trafford. He left like a correctly priced asset — no more, no less.

Twelve months later, he stood in the middle of a circle of teammates in Naples, lifting the Serie A trophy. First season in Italy: 12 goals, 6 assists. Numbers that no central midfielder in Serie A reaches easily.

Then, in January 2026, a line quietly appeared among the market reports: Manchester United wants to bring McTominay back. Aston Villa had also asked. The story of the "lost son returning" began to be told, with all the emotional seasoning of an academy product sold cheaply who has now become a champion.

But buried in the middle of the article, hidden beneath the dazzling numbers, is a detail the headline never mentions: in the summer of 2026, McTominay underwent heart surgery. This entire season, he has barely played. That is the single most important fact in the whole story, and it is not where readers usually look first.

---

To read this story correctly, I need to reconstruct the evidence chain from the start, rather than let emotion lead. In 2026, Manchester United sold McTominay to Napoli for 30 million euros. The contract runs four years, to mid-2028. Under straight-line amortization — a tool I have used since my days building the K-League FFP spreadsheet — the book value drops by roughly 7.5 million euros per year. After the current season, the remaining book value is approximately 15 million euros. This is the foundational figure any negotiation must pass through.

On the pitch, the deal has been a resounding success. Napoli won Serie A. McTominay scored 12 and assisted 6. For a central midfielder in one of Europe's top five leagues, that is a rare number. He became the main man in his very first season, and not by accident.

Then, in the summer of 2026, he underwent heart surgery. The 2026/26 season has been largely lost to fitness issues. Meanwhile, contract renewal talks between him and Napoli have stalled over wages: Napoli cannot meet his demands. The wider transfer market context matters too — Serie A is increasingly struggling to keep its stars against the financial might of the Premier League. This is the familiar story of European football's food chain, where an Italian side wins on the pitch but loses in the negotiation room.

---

Now comes the core. And I must be blunt: this is where we need to separate fact from constructed narrative.

The strongest and most defensible element of the entire dossier lies in the playing record: McTominay's value comes from his ability to contribute goals from a central midfield position, a scarce commodity in the transfer market. 12 goals and 6 assists in his first Serie A season is not a random product. It is the result of a deliberately coached role — the box-to-box midfielder who arrives late in the box, known as a mezzala in Italian football. He is not a pure defensive midfielder. He is a hidden attacking weapon behind the forward line.

Based on my experience watching Napoli's matches during their title-winning season, I noticed something telling: most of McTominay's goals came from box arrivals late in games, when the opponent's defensive structure had broken down. He appears at exactly the right moment, in exactly the right place, as if he has an internal clock. That is not the skill of a classic central midfielder. It is the instinct of a disguised striker.

But precisely for that reason, his value depends entirely on the system: if a club buys him and plays him as a defensive No. 6, the entire value collapses immediately. This is the biggest blind spot that both buyer and seller tend to overlook when they look at the stat sheet. A midfielder who scores 12 goals looks very attractive on paper. But that number is only reproducible if he continues to be granted license to push forward, and behind him there is an anchor midfielder good enough to cover the space.

Financially, this deal has an interesting paradox. Bought for 30 million euros in 2026 with a contract to mid-2028, the remaining book value after this season is around 15 million euros. That means: if Napoli sell him, they need a price above 15 million euros just to avoid a book loss. This is a hidden floor that no article mentions, but it governs every negotiation. Selling below that threshold is an admission of financial failure. Selling above it, for a player who just had heart surgery, is a hard equation.

And here is where I must stop before a detail that troubles me. The original article claims Napoli "must sell him next summer if they want to receive a fee." But the same article states his contract runs to mid-2028. These two things cannot both be true under normal circumstances. A player under contract to 2028 retains his value for more than two more years — there is no forced-sale deadline next summer. The "must sell" claim is either a misstatement, a reference to an undisclosed release clause, or simply a translation error. Whichever it is, readers are being led by a false premise.

The more credible driver is the wage impasse. If Napoli genuinely cannot meet McTominay's demands, the renewal risk is real. But that points to a renegotiation or a future sale — not an urgent fire sale. This is the difference between pressure and crisis, and the media routinely conflates the two.

As for the medical dimension — the fact buried mid-article — I must be clear: the heart surgery is the single largest valuation risk in the entire dossier. A player with impaired availability will be heavily discounted in any club's medical due diligence. Accounting amortization does not protect an asset from medical-driven impairment. This is a basic principle of sports investment, and it is often forgotten when the goal numbers are too impressive.

On the competitive landscape between leagues, this is a food-chain story. Napoli are Serie A champions but constrained by a wage ceiling. Manchester United and Aston Villa are both Premier League clubs with European ambitions and superior financial power. The flow of talent from Italy to England is not an isolated phenomenon — it is structural. Each such transfer further reinforces the Premier League's financial dominance in the talent market.

One notable regulatory detail: enquiries by Manchester United and Aston Villa are lawful only if all contact is made through Napoli with the club's knowledge. Direct contact with the player or agent without permission would constitute tapping-up. The article does not state which occurred. The presence of two simultaneous Premier League enquiries is often consistent with an agent-led market-testing campaign — a legal move, but usually a prelude to a formal club-to-club approach.

And here, I must speak about motive. A public narrative of "Premier League interest" is a classic lever to pressure a wage renewal — precisely the negotiation currently stalled over wages. The agent has a motive to inflate the level of interest. I am not saying anyone did anything wrong. I am only saying that when a renewal stalls and suddenly rumors surface about two Premier League clubs at once, I always ask: who benefits most?

---

On the possibility of reproducing his form, I need to be cautious. The entire market story rests on last season's data. The current season offers almost no sample to assess, because McTominay has barely played. This is the crucial difference between a player at his peak and a player entering a post-surgery recovery phase. The market is pricing him on the memory of the 2026/25 season, not on the reality of the 2026/26 season.

I have seen this pattern many times in my career. Russia 2026 was not where I started writing, but where I started listening. Every source is a person. And those people, when they tell me about an inflated player, usually say the same thing: look at the minutes played, not the goals scored. A player can score 12 goals in a season, but if he disappears the next season, those 12 goals are just a beautiful memory, not a priceable asset.

On the national-team dimension, the original article completely omits an angle that should appear. McTominay is a Scotland international. A season lost to surgery directly affects his availability for the national team. This is a downstream ripple effect no one mentions, but it matters to both the player and the Scottish FA.

On the fan side, the "hero leaves" story has a special emotional pull. An academy product, sold for a modest fee, now a champion, potentially returning. This is the kind of story that generates engagement independent of its accuracy — traffic value above sporting value. And when traffic value exceeds sporting value, I am always cautious about every number presented.

---

Here, I must state my contrarian angle.

The entire headline — "Manchester United wants to re-sign McTominay" — overstates the evidence. The only attributed point in the original article is a speculation report from Sky Sports and a past enquiry. That is not a current, confirmed intention. The rest of the article — 14 information points — is unattributed. This materially lowers the evidentiary weight of every conclusion.

And there are two internal contradictions in the original article itself. First, the "must sell next summer" claim contradicts the contract to 2028. Second, the "12 goals" figure and the phrase "no fewer than ten times" appear to describe the same season in two inconsistent ways. Both points weaken source reliability.

I have learned one thing in many years in this profession: the stadium corridor taught me that, there, a whisper is always truer than applause. The loudest articles are usually the ones with the least evidence. And this is one of them.

The correct story is not "Manchester United wants to re-sign McTominay." The correct story is: a 29-year-old player, just out of heart surgery, who has barely played all season, under contract to 2028 with a club that cannot meet his wage demands, while two Premier League clubs are reported to be interested. That is a story about medical risk, financial deadlock, and market pressure — not a heartwarming reunion.

---

So where does the next domino fall?

I believe the real decision will not lie with Manchester United or Aston Villa, but with Napoli itself. The Italian club must choose: keep a player who has proven his value but carries a major fitness question mark, or convert him into cash before the book value becomes a burden. If they choose the latter, watch the contract structure: any club buying a player just out of heart surgery will almost certainly include appearance-based add-ons and medical conditions. That is the structural consequence no article mentions, but it will shape the true value of the deal.

Hasty news fades. Patient sources always finish first. I will not rush to conclude on Scott McTominay's future. I will only ask a question: when a player just out of heart surgery is priced on the memory of a past season, who truly holds the risk — the buyer, the seller, or himself?